Cargando…
Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy
Epilepsy is one of the most common neurological disorders in pediatric patients with other underlying neurological defects. Identifying the underlying etiology is crucial for better management of the disorder. We performed trio-whole exome sequencing in 221 pediatric patients with epilepsy. Probands...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417468/ https://www.ncbi.nlm.nih.gov/pubmed/34489640 http://dx.doi.org/10.3389/fnmol.2021.699574 |
_version_ | 1783748387400581120 |
---|---|
author | Jiang, Tiejia Gao, Jia Jiang, Lihua Xu, Lu Zhao, Congying Su, Xiaojun Shen, Yaping Gu, Weiyue Kong, Xiaohong Yang, Ying Gao, Feng |
author_facet | Jiang, Tiejia Gao, Jia Jiang, Lihua Xu, Lu Zhao, Congying Su, Xiaojun Shen, Yaping Gu, Weiyue Kong, Xiaohong Yang, Ying Gao, Feng |
author_sort | Jiang, Tiejia |
collection | PubMed |
description | Epilepsy is one of the most common neurological disorders in pediatric patients with other underlying neurological defects. Identifying the underlying etiology is crucial for better management of the disorder. We performed trio-whole exome sequencing in 221 pediatric patients with epilepsy. Probands were divided into seizures with developmental delay/intellectual disability (DD/ID) and seizures without DD/ID groups. Pathogenic (P) or likely pathogenic (LP) variants were identified in 71/110 (64.5%) patients in the seizures with DD/ID group and 21/111 (18.9%) patients in the seizures without DD/ID group (P < 0.001). Eighty-seven distinct P/LP single nucleotide variants (SNVs)/insertion deletions (Indels) were detected, with 55.2% (48/87) of them being novel. All aneuploidy and P/LP copy number variants (CNVs) larger than 100 Kb were identifiable by both whole-exome sequencing and copy number variation sequencing (CNVseq) in 123 of individuals (41 pedigrees). Ten of P/LP CNVs in nine patients and one aneuploidy variant in one patient (Patient #56, #47, XXY) were identified by CNVseq. Herein, we identified seven genes (NCL, SEPHS2, PA2G4, SLC35G2, MYO1C, GPR158, and POU3F1) with de novo variants but unknown pathogenicity that were not previously associated with epilepsy. Potential effective treatment options were available for 32 patients with a P/LP variant, based on the molecular diagnosis. Genetic testing may help identify the molecular etiology of early onset epilepsy and DD/ID and further aid to choose the appropriate treatment strategy for patients. |
format | Online Article Text |
id | pubmed-8417468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84174682021-09-05 Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy Jiang, Tiejia Gao, Jia Jiang, Lihua Xu, Lu Zhao, Congying Su, Xiaojun Shen, Yaping Gu, Weiyue Kong, Xiaohong Yang, Ying Gao, Feng Front Mol Neurosci Neuroscience Epilepsy is one of the most common neurological disorders in pediatric patients with other underlying neurological defects. Identifying the underlying etiology is crucial for better management of the disorder. We performed trio-whole exome sequencing in 221 pediatric patients with epilepsy. Probands were divided into seizures with developmental delay/intellectual disability (DD/ID) and seizures without DD/ID groups. Pathogenic (P) or likely pathogenic (LP) variants were identified in 71/110 (64.5%) patients in the seizures with DD/ID group and 21/111 (18.9%) patients in the seizures without DD/ID group (P < 0.001). Eighty-seven distinct P/LP single nucleotide variants (SNVs)/insertion deletions (Indels) were detected, with 55.2% (48/87) of them being novel. All aneuploidy and P/LP copy number variants (CNVs) larger than 100 Kb were identifiable by both whole-exome sequencing and copy number variation sequencing (CNVseq) in 123 of individuals (41 pedigrees). Ten of P/LP CNVs in nine patients and one aneuploidy variant in one patient (Patient #56, #47, XXY) were identified by CNVseq. Herein, we identified seven genes (NCL, SEPHS2, PA2G4, SLC35G2, MYO1C, GPR158, and POU3F1) with de novo variants but unknown pathogenicity that were not previously associated with epilepsy. Potential effective treatment options were available for 32 patients with a P/LP variant, based on the molecular diagnosis. Genetic testing may help identify the molecular etiology of early onset epilepsy and DD/ID and further aid to choose the appropriate treatment strategy for patients. Frontiers Media S.A. 2021-08-19 /pmc/articles/PMC8417468/ /pubmed/34489640 http://dx.doi.org/10.3389/fnmol.2021.699574 Text en Copyright © 2021 Jiang, Gao, Jiang, Xu, Zhao, Su, Shen, Gu, Kong, Yang and Gao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Jiang, Tiejia Gao, Jia Jiang, Lihua Xu, Lu Zhao, Congying Su, Xiaojun Shen, Yaping Gu, Weiyue Kong, Xiaohong Yang, Ying Gao, Feng Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy |
title | Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy |
title_full | Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy |
title_fullStr | Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy |
title_full_unstemmed | Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy |
title_short | Application of Trio-Whole Exome Sequencing in Genetic Diagnosis and Therapy in Chinese Children With Epilepsy |
title_sort | application of trio-whole exome sequencing in genetic diagnosis and therapy in chinese children with epilepsy |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417468/ https://www.ncbi.nlm.nih.gov/pubmed/34489640 http://dx.doi.org/10.3389/fnmol.2021.699574 |
work_keys_str_mv | AT jiangtiejia applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT gaojia applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT jianglihua applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT xulu applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT zhaocongying applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT suxiaojun applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT shenyaping applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT guweiyue applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT kongxiaohong applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT yangying applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy AT gaofeng applicationoftriowholeexomesequencingingeneticdiagnosisandtherapyinchinesechildrenwithepilepsy |